申请人:Hisamitsu Pharmaceutical Co, Inc.
公开号:US05665348A1
公开(公告)日:1997-09-09
A cholesterol-lowering drug which comprises, as the main ingredient, a non-crosslinked anion exchange resin consisting of structural units represented by the general formula (I): ##STR1## wherein R.sub.1 represents a benzyl group or an alkyl group having 1 to 20 carbon atoms, R.sub.2 and R.sub.3 may be identical with, or different from, each other and each represent a lower alkyl group having 1 to 4 carbon atoms, R.sub.4 represents a hydrogen atom or a lower alkyl group, X represents a physiologically acceptable counter ion, n is an integer of from 1 to 3, and p is an average degree of polymerization ranging from 10 to 10,000.
一种降低胆固醇的药物,其主要成分为非交联阴离子交换树脂,由结构单元表示为通式(I):##STR1## 其中,R.sub.1代表苄基或具有1至20个碳原子的烷基基团,R.sub.2和R.sub.3可以相同或不同,分别代表具有1至4个碳原子的低烷基基团,R.sub.4代表氢原子或低烷基基团,X代表生理上可接受的阴离子,n为1至3的整数,p为平均聚合度,范围为10至10,000。